# CYCN (Korsana Biosciences, Inc.) - SEC EDGAR Financial Statements

> Korsana Biosciences, Inc. reported $2.07M in revenue and a net loss of $58.88M for the fiscal year ended December 31, 2025 (up 3.7% year over year), with a -481.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/CYCN
- Markdown: https://convexityos.com/fundamentals/CYCN.md
- SEC CIK: 0001755237
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:47 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001755237&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $2.07M | +3.7% YoY |
| Operating Income | FY 2025 | -$9.98M | -481.1% margin |
| Net Income | FY 2025 | -$58.88M | -2838.7% net margin |
| Diluted EPS | FY 2025 | -$4.35 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $456.2M | Total debt: $1.27M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.07M | $2.00M | $0 | $297K | $3.94M | $2.30M | $4.51M | -- |
| Research & Development | $959K | $286K | $1.51M | $5.98M | $37.64M | $56.41M | $95.14M | $87.72M |
| Total Operating Expenses | $7.05M | $5.63M | $12.95M | $18.84M | $59.14M | $83.56M | $129.5M | $115.3M |
| **Operating Income** | -$4.97M | -$3.63M | -$12.95M | -$18.54M | -$55.20M | -$81.27M | -$125.0M | -$115.3M |
| **EBITDA** | -- | -- | -$12.95M | -$18.48M | -$54.72M | -$78.97M | -$122.3M | -$113.7M |
| Income Before Tax | -$3.53M | -$3.06M | -$5.26M | -$44.08M | -$51.65M | -$122.4M | -$122.4M | -$115.3M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$3.53M | -$3.06M | -$5.26M | -$44.08M | -$51.65M | -$77.80M | -$123.0M | -$115.3M |
| Basic EPS | -$1.11 | -$1.21 | -$2.25 | -$20.28 | -$26.40 | -$51.20 | -$89.80 | -$84.20 |
| **Diluted EPS** | -$1.11 | -$1.21 | -$2.25 | -$20.28 | -$26.40 | -$51.20 | -$89.80 | -$84.20 |
| Basic Shares Outstanding | 3.2M | 2.5M | 2.3M | 2.2M | 2.0M | 1.5M | 1.4M | 1.4K |
| Diluted Shares Outstanding | 3.2M | 2.5M | 2.3M | 2.2M | 2.0M | 1.5M | 1.4M | 1.4K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | $0 | $0 | $1.02M | $875K | $93K | $81K | $1.81M |
| Research & Development | $42K | $0 | $730K | $938K | $20K | $56K | $36K | $56K |
| Total Operating Expenses | $48K | $1.77M | $3.21M | $7.02M | $22K | $1.76M | $1.54M | $1.30M |
| **Operating Income** | -$48K | -$1.77M | -$3.21M | -$4.95M | -$22K | -$1.67M | -$1.46M | $502K |
| Income Tax Expense | $0 | -- | -- | -- | $0 | -- | -- | -- |
| **Net Income** | -$46.42M | -$17.36M | -$13.51M | $18.42M | -$21.72M | -$152K | -$73K | $530K |
| Basic EPS | -$3.19 | -$0.41 | -$0.76 | -- | -$39.49 | -$0.11 | -$0.56 | -- |
| **Diluted EPS** | -$3.19 | -$0.41 | -$0.76 | -- | -$39.49 | -$0.11 | -$0.56 | -- |
| Basic Shares Outstanding | 13.5M | 4.3M | 4.2M | -- | 550.1K | 3.1M | 2.6M | -- |
| Diluted Shares Outstanding | 13.5M | 4.3M | 4.2M | -- | 550.1K | 3.1M | 2.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $154.1M | $3.23M | $7.57M | $13.38M | $53.96M | $54.40M | $94.89M | -- |
| **Cash & Short-Term Investments** | $154.1M | $3.23M | $7.57M | $13.38M | $53.96M | $54.40M | $94.89M | -- |
| Accounts Receivable, Net | $1.00M | $556K | $0 | $96K | $100K | $0 | -- | -- |
| Other Current Assets | $11K | $16K | $11K | $537K | $468K | $3.16M | $2.86M | $12K |
| **Total Current Assets** | $154.6M | $4.22M | $8.02M | $14.82M | $55.46M | $58.50M | $101.2M | $879K |
| Property, Plant & Equipment, Net | $0 | $0 | $0 | $0 | $65K | $6.87M | $11.61M | $6.50M |
| Other Non-Current Assets | -- | -- | $0 | $2.04M | $2.41M | $2.77M | $540K | $25K |
| **Total Non-Current Assets** | $0 | $5.35M | $5.35M | $3.26M | $3.87M | $56.88M | $85.28M | $6.52M |
| **Total Assets** | $154.6M | $9.57M | $13.37M | $18.08M | $59.33M | $115.4M | $186.5M | $7.40M |
| Accounts Payable | $176K | $390K | $1.20M | $2.97M | $1.83M | $1.15M | $3.23M | $2.78M |
| Short-Term Debt | -- | -- | -- | $3.50M | $3.50M | $3.50M | -- | -- |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $9.80M |
| **Total Current Liabilities** | $12.49M | $725K | $2.09M | $7.63M | $11.09M | $16.95M | $18.25M | $17.85M |
| **Total Non-Current Liabilities** | $538K | $0 | $0 | $0 | $0 | $38.93M | $70.50M | $0 |
| **Total Liabilities** | $13.03M | $725K | $2.09M | $7.63M | $11.09M | $55.88M | $88.75M | $17.85M |
| **Total Debt (incl. Leases)** | -- | -- | -- | $3.50M | $3.50M | $45.73M | $73.92M | -- |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | -- | -- |
| Retained Earnings | -$35.73M | -$267.5M | -$264.4M | -$259.2M | -$215.1M | -$163.4M | -$85.63M | -- |
| Accumulated Other Comp. Income | -- | $0 | -$12K | -$20K | -$23K | -$27K | -$20K | -- |
| **Total Stockholders' Equity** | -$33.97M | $66K | $11.29M | $10.45M | $48.25M | $59.49M | $97.73M | -$10.45M |
| Total Equity | $9.09M | $8.85M | $11.29M | $10.45M | $48.25M | $59.49M | $97.73M | -$10.45M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $456.2M | $1.39M | $2.82M | $154.1M | $4.57M | $3.01M | $3.64M | $3.23M |
| **Cash & Short-Term Investments** | $456.2M | $1.39M | $2.82M | $154.1M | $4.57M | $3.01M | $3.64M | $3.23M |
| Accounts Receivable, Net | -- | $0 | $0 | $1.00M | $100K | $525K | $581K | $556K |
| Other Current Assets | -- | $11K | $11K | $11K | $11K | $27K | $21K | $16K |
| **Total Current Assets** | $460.6M | $1.51M | $3.09M | $154.6M | $5.07M | $4.02M | $4.50M | $4.22M |
| Property, Plant & Equipment, Net | $367K | $66K | $66K | $0 | $0 | $0 | $0 | $0 |
| **Total Non-Current Assets** | $1.44M | $5.42M | $5.42M | $0 | $5.35M | $5.35M | $5.35M | $5.35M |
| **Total Assets** | $462.1M | $6.93M | $8.51M | $154.6M | $10.41M | $9.37M | $9.85M | $9.57M |
| Accounts Payable | $1.61M | $1.60M | $457K | $176K | $480K | $462K | $483K | $390K |
| **Total Current Liabilities** | $44.20M | $1.84M | $1.71M | $12.49M | $877K | $800K | $1.07M | $725K |
| **Total Non-Current Liabilities** | $1.36M | $0 | $0 | $538K | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $45.56M | $1.84M | $1.71M | $13.03M | $877K | $800K | $1.07M | $725K |
| **Total Debt (incl. Leases)** | $1.27M | -- | -- | -- | -- | -- | -- | -- |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$113.0M | -$276.0M | -$274.2M | -$35.73M | -$270.2M | -$269.2M | -$268.9M | -$267.5M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Stockholders' Equity** | $391.6M | -$63.28M | -$47.03M | -$33.97M | -$21.84M | -$123K | $16K | $66K |
| Total Equity | $391.6M | $5.09M | $6.79M | $9.09M | $9.54M | $8.57M | $8.78M | $8.85M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.53M | -$3.06M | -$5.26M | -$44.08M | -$51.65M | -$77.80M | -$123.0M | -$115.3M |
| Depreciation & Amortization | -- | -- | $0 | $65K | $472K | $2.30M | $2.70M | $1.53M |
| Stock-Based Compensation | $441K | $625K | $1.07M | $6.25M | $9.61M | $14.99M | $19.63M | $12.43M |
| Change in Receivables | -$444K | -$556K | $96K | $4.0K | -$100K | $0 | -- | -- |
| Change in Payables | $118K | -$445K | -$1.77M | $1.14M | $679K | -$1.30M | -$331K | $979K |
| **Operating Cash Flow** | -$3.31M | -$4.33M | -$21.25M | -$40.61M | -$36.52M | -$72.49M | -$102.2M | -$97.50M |
| Capital Expenditure | -- | -- | -- | $0 | -$7.0K | -$1.52M | -$6.89M | -$3.44M |
| **Free Cash Flow** | -- | -- | -- | -$40.61M | -$36.52M | -$74.01M | -$109.1M | -$100.9M |
| **Investing Cash Flow** | -- | $0 | $10.40M | $0 | $1.46M | $18K | -$6.71M | -$3.44M |
| Common Stock Issued | $1.38M | $0 | $5.00M | $0 | -- | -- | -- | -- |
| **Financing Cash Flow** | $3.32M | $0 | $5.02M | $29K | $30.79M | $28.09M | $211.6M | $100.9M |
| **Net Change in Cash** | $8.0K | -$4.34M | -$5.81M | -$40.58M | -$4.27M | -$44.39M | $102.6M | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$46.40M | -$1.75M | -$3.18M | $18.42M | -$20.20M | -$324K | -$1.43M | $530K |
| Stock-Based Compensation | $17.31M | $51K | $58K | $196K | $17K | $114K | $114K | $122K |
| Change in Receivables | -- | $0 | $1.00M | -$900K | $425K | $56K | -$25K | -$556K |
| Change in Payables | $343K | $1.14M | -$51K | -$9.73M | $9.78M | -$21K | $93K | $86K |
| **Operating Cash Flow** | -$46.83M | -$1.43M | -$1.18M | $8.48M | -$10.33M | -$503K | -$968K | $360K |
| Capital Expenditure | -$231K | $0 | -$66K | -- | $0 | $0 | $0 | -- |
| **Free Cash Flow** | -$47.06M | -$1.43M | -$1.24M | -- | -$10.33M | -$503K | -$968K | -- |
| **Investing Cash Flow** | -$231K | $0 | -$66K | -- | $0 | $0 | $0 | -- |
| Common Stock Issued | -- | -- | -- | $0 | $0 | $0 | $1.38M | $0 |
| **Financing Cash Flow** | $351.1M | $0 | $825K | -$162.3M | $164.3M | -$130K | $1.38M | $0 |
| **Net Change in Cash** | $304.0M | -$1.43M | -$417K | -$153.8M | $154.0M | -$633K | $407K | $360K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -239.8% | -181.4% | -- | -6242.4% | -1400.2% | -3539.4% | -2774.3% | -- |
| **Net Profit Margin** | -170.1% | -152.8% | -- | -14841.1% | -1310.2% | -3388.6% | -2729.3% | -- |
| Return on Equity (ROE) | -- | -4631.8% | -46.6% | -421.7% | -107.0% | -130.8% | -125.9% | -- |
| Return on Assets (ROA) | -2.3% | -31.9% | -39.4% | -243.8% | -87.0% | -67.4% | -66.0% | -1557.2% |
| Current Ratio | 12.38x | 5.83x | 3.85x | 1.94x | 5.00x | 3.45x | 5.55x | 0.05x |
| Quick Ratio | 12.42x | 5.22x | 3.63x | 1.77x | 4.88x | 3.21x | 5.20x | -- |
| Debt to Equity | -- | -- | -- | 0.33x | 0.07x | 0.77x | 0.76x | -- |
| **Revenue Growth (YoY)** | +3.7% | -- | -100.0% | -92.5% | +71.7% | -49.1% | -- | -- |
| 5Y Revenue / Share Growth | -56.8% | -75.9% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -523.8% | -494.4% | -390.6% | -92.8% | -172.7% | -166.6% | -181.4% |
| **Net Profit Margin** | -- | -1798.6% | -851.2% | -170.1% | -750.2% | -19.2% | -76.3% | -152.8% |
| Return on Equity (ROE) | -15.0% | -- | -- | -- | -- | -- | -9925.0% | -4631.8% |
| Return on Assets (ROA) | -12.7% | -493.1% | -199.5% | -2.3% | -205.6% | -4.5% | -16.1% | -31.9% |
| Current Ratio | 10.42x | 0.82x | 1.80x | 12.38x | 5.78x | 5.03x | 4.21x | 5.83x |
| Quick Ratio | 10.32x | 0.75x | 1.65x | 12.42x | 5.32x | 4.41x | 3.96x | 5.22x |
| Debt to Equity | 0.00x | -- | -- | -- | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -100.0% | -100.0% | -43.2% | +351.0% | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -1086.2% | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | +3375.5% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | +2256.9% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
